Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
Conditions
Type 2 Diabetes Mellitus · T2DM
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Desert Clinical Research, Mesa, Arizona, United States
Contact: Principal Investigator (Gerald Shockey)Charter Research, Orlando, Florida, United States
Contact: Principal Investigator (Mary Hilal Quarterman)AdventHealth Translational Research Institute, Orlando, Florida, United States
Contact: Principal Investigator (Richard Edwin Pratley)Centricity Research IRT - DBA IACT Health Columbus Piedmont, Columbus, Georgia, United States
Contact: Principal Investigator (Steven Leichter)The South Bend Clinic, South Bend, Indiana, United States
Contact: Principal Investigator (Rita Schmid)Jefferson City Medical Center, Jefferson City, Missouri, United States
Contact: Principal Investigator (Benjamin Cook)Clay Platte Family Medicine, Kansas City, Missouri, United States
Contact: Principal Investigator (Scott Kuennen)Methodist Physicians Clinic, Fremont, Nebraska, United States
Contact: Principal Investigator (Thomas Wolf)Santa Rosa Medical Centers of Nevada, Las Vegas, Nevada, United States
Contact: Principal Investigator (Syed Pervaiz)Lucas Research, Inc., Morehead City, North Carolina, United States
Contact: Principal Investigator (Kathryn Jean Lucas)Centricity Research Columbus, Columbus, Ohio, United States
Contact: Principal Investigator (Sridhar Guduri)Olympus Family Medicine, Salt Lake City, Utah, United States
Contact: Principal Investigator (Jared Probst)Manassas Clinical Research Center, Manassas, Virginia, United States
Contact: Principal Investigator (Nabil Saleh Andrawis)